Illinois General Assembly - Full Text of Public Act 094-0694
Illinois General Assembly

Previous General Assemblies

Public Act 094-0694


 

Public Act 0694 94TH GENERAL ASSEMBLY



 


 
Public Act 094-0694
 
SB0273 Enrolled LRB094 04221 RLC 34245 b

    AN ACT concerning criminal law.
 
    Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
 
    Section 1. Short title. This Act may be cited as the
Methamphetamine Precursor Control Act.
 
    Section 5. Purpose. The purpose of this Act is to reduce
the harm that methamphetamine manufacturing and manufacturers
are inflicting on individuals, families, communities, first
responders, the economy, and the environment in Illinois, by
making it more difficult for persons engaged in the unlawful
manufacture of methamphetamine and related activities to
obtain methamphetamine's essential ingredient, ephedrine or
pseudoephedrine.
 
    Section 10. Definitions. In this Act:
    "Administer" or "administration" has the meaning provided
in Section 102 of the Illinois Controlled Substances Act.
    "Agent" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "Convenience package" means any package that contains 360
milligrams or less of ephedrine or pseudoephedrine, their salts
or optical isomers, or salts of optical isomers in liquid or
liquid-filled capsule form.
    "Deliver" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "Dispense" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "Distribute" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "List I chemical" has the meaning provided in 21 U.S.C.
Section 802.
    "Methamphetamine precursor" has the meaning provided in
Section 10 of the Methamphetamine Control and Community
Protection Act.
    "Package" means an item packaged and marked for retail sale
that is not designed to be further broken down or subdivided
for the purpose of retail sale.
    "Pharmacist" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "Pharmacy" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "Practitioner" has the meaning provided in Section 102 of
the Illinois Controlled Substances Act.
    "Prescriber" has the meaning provided in Section 102 of the
Illinois Controlled Substances Act.
    "Prescription" has the meaning provided in Section 102 of
the Illinois Controlled Substances Act.
    "Readily retrievable" has the meaning provided in 21 C.F.R.
part 1300.
    "Retail distributor" means a grocery store, general
merchandise store, drug store, other merchandise store, or
other entity or person whose activities as a distributor
relating to drug products containing targeted methamphetamine
precursor are limited exclusively or almost exclusively to
sales for personal use by an ultimate user, both in number of
sales and volume of sales, either directly to walk-in customers
or in face-to-face transactions by direct sales.
    "Sales employee" means any employee or agent who at any
time (a) operates a cash register at which targeted packages
may be sold, (b) works at or behind a pharmacy counter, (c)
stocks shelves containing targeted packages, or (d) trains or
supervises any other employee or agent who engages in any of
the preceding activities.
    "Single retail transaction" means a sale by a retail
distributor to a specific customer at a specific time.
    "Targeted methamphetamine precursor" means any compound,
mixture, or preparation that contains any detectable quantity
of ephedrine or pseudoephedrine, their salts or optical
isomers, or salts of optical isomers.
    "Targeted package" means a package, including a
convenience package, containing any amount of targeted
methamphetamine precursor.
    "Ultimate user" has the meaning provided in Section 102 of
the Illinois Controlled Substances Act.
 
    Section 15. Basic provisions.
    (a) No targeted methamphetamine precursor shall be
purchased, received, or otherwise acquired in any manner other
than that described in Section 20 of this Act.
    (b) No targeted methamphetamine precursor shall be
knowingly administered, dispensed, or distributed for any
purpose other than a medical purpose.
    (c) No targeted methamphetamine precursor shall be
knowingly administered, dispensed, or distributed for the
purpose of violating or evading this Act, the Illinois
Controlled Substances Act, or the Methamphetamine Control and
Community Protection Act.
    (d) No targeted methamphetamine precursor shall be
administered, dispensed, or distributed with knowledge that it
will be used to manufacture methamphetamine or with reckless
disregard of its likely use to manufacture methamphetamine.
    (e) No targeted methamphetamine precursor shall be
administered, dispensed, or distributed except by:
        (1) a pharmacist pursuant to the valid order of a
    prescriber;
        (2) any other practitioner authorized to do so by the
    Illinois Controlled Substances Act;
        (3) a drug abuse treatment program, pursuant to
    subsection (d) of Section 313 of the Illinois Controlled
    Substances Act;
        (4) a pharmacy pursuant to Section 25 of this Act;
        (5) a retail distributor pursuant to Sections 30 and 35
    of this Act; or
        (6) a distributor authorized by the Drug Enforcement
    Administration to distribute bulk quantities of a list I
    chemical under the federal Controlled Substances Act and
    corresponding regulations, or the employee or agent of such
    a distributor acting in the normal course of business.
 
    Section 20. Restrictions on purchase, receipt, or
acquisition.
    (a) Except as provided in subsection (e) of this Section,
any person 18 years of age or older wishing to purchase,
receive, or otherwise acquire a targeted methamphetamine
precursor shall, prior to taking possession of the targeted
methamphetamine precursor:
        (1) provide a driver's license or other
    government-issued identification showing the person's
    name, date of birth, and photograph; and
        (2) sign a log documenting the name and address of the
    person, date and time of the transaction, and brand and
    product name and total quantity distributed of ephedrine or
    pseudoephedrine, their salts, or optical isomers, or salts
    of optical isomers.
    (b) Except as provided in subsection (e) of this Section,
no person shall knowingly purchase, receive, or otherwise
acquire, within any 30-day period products containing more than
a total of 7,500 milligrams of ephedrine or pseudoephedrine,
their salts or optical isomers, or salts of optical isomers.
    (c) Except as provided in subsections (d) and (e) of this
Section, no person shall knowingly purchase, receive, or
otherwise acquire more than 2 targeted packages in a single
retail transaction.
    (d) Except as provided in subsection (e) of this Section,
no person shall knowingly purchase, receive, or otherwise
acquire more than one convenience package in a 24-hour period.
    (e) This Section shall not apply to any person who
purchases, receives, or otherwise acquires a targeted
methamphetamine precursor for the purpose of dispensing,
distributing, or administering it in a lawful manner described
in subsection (e) of Section 15 of this Act.
 
    Section 25. Pharmacies.
    (a) No targeted methamphetamine precursor may be knowingly
distributed through a pharmacy, including a pharmacy located
within, owned by, operated by, or associated with a retail
distributor unless all terms of this Section are satisfied.
    (b) The targeted methamphetamine precursor shall:
        (1) be packaged in blister packs, with each blister
    containing not more than 2 dosage units, or when the use of
    blister packs is technically infeasible, in unit dose
    packets; and
        (2) contain no more than 3,000 milligrams of ephedrine
    or pseudoephedrine, their salts or optical isomers, or
    salts of optical isomers.
    (c) The targeted methamphetamine precursor shall be stored
behind the pharmacy counter and distributed by a pharmacist or
pharmacy technician licensed under the Pharmacy Practice Act of
1987.
    (d) Any retail distributor operating a pharmacy, and any
pharmacist or pharmacy technician involved in the transaction
or transactions, shall ensure that any person purchasing,
receiving, or otherwise acquiring the targeted methamphetamine
precursor complies with subsection (a) of Section 20 of this
Act.
    (e) Any retail distributor operating a pharmacy, and any
pharmacist or pharmacy technician involved in the transaction
or transactions, shall verify that:
        (1) The person purchasing, receiving, or otherwise
    acquiring the targeted methamphetamine precursor is 18
    years of age or older and resembles the photograph of the
    person on the government-issued identification presented
    by the person; and
        (2) The name entered into the log referred to in
    subsection (a) of Section 20 of this Act corresponds to the
    name on the government-issued identification presented by
    the person.
    (f) The logs referred to in subsection (a) of Section 20 of
this Act shall be kept confidential, maintained for not less
than 2 years, and made available for inspection and copying by
any law enforcement officer upon request of that officer. These
logs may be kept in an electronic format if they include all
the information specified in subsection (a) of Section 20 of
this Act in a manner that is readily retrievable and
reproducible in hard-copy format.
    (g) No retail distributor operating a pharmacy, and no
pharmacist or pharmacy technician, shall knowingly distribute
any targeted methamphetamine precursor to any person under 18
years of age.
    (h) No retail distributor operating a pharmacy, and no
pharmacist or pharmacy technician, shall knowingly distribute
to a single person in any 24-hour period more than one
convenience package.
    (i) Except as provided in subsection (h) of this Section,
no retail distributor operating a pharmacy, and no pharmacist
or pharmacy technician, shall knowingly distribute to a single
person more than 2 targeted packages in a single retail
transaction.
    (j) No retail distributor operating a pharmacy, and no
pharmacist or pharmacy technician, shall knowingly distribute
to a single person in any 30-day period products containing
more than a total of 7,500 milligrams of ephedrine or
pseudoephedrine, their salts or optical isomers, or salts of
optical isomers.
 
    Section 30. Retail distributors; general requirements.
    (a) No retail distributor shall distribute any convenience
package except in accordance with this Section and Section 35
of this Act.
    (b) The convenience packages must be displayed behind store
counters or in locked cases, so that customers are not able to
reach the product without the assistance of a store employee or
agent.
    (c) The retailer distributor shall ensure that any person
purchasing, receiving, or otherwise acquiring the targeted
methamphetamine precursor complies with subsection (a) of
Section 20 of this Act.
    (d) The retail distributor shall verify that:
        (1) The person purchasing, receiving, or otherwise
    acquiring the targeted methamphetamine precursor is 18
    years of age or older and resembles the photograph of the
    person on the government-issued identification presented
    by the person; and
        (2) The name entered into the log referred to in
    subsection (a) of Section 20 of this Act corresponds to the
    name on the government-issued identification presented by
    the person.
    (e) The logs referred to in subsection (a) of Section 20 of
this Act shall be kept confidential, maintained for not less
than 2 years, and made available for inspection and copying by
any law enforcement officer upon request of that officer. These
logs may be kept in an electronic format if they include all
the information specified in subsection (a) of Section 20 of
this Act in a form that is readily retrievable.
    (f) No retail distributor shall knowingly distribute any
targeted methamphetamine precursor to any person under 18 years
of age.
    (g) No retail distributor shall knowingly distribute to a
single person in any 24-hour period more than one convenience
package.
    (h) No retail distributor shall knowingly distribute to a
single person in any 30-day period products containing more
than a total of 7,500 milligrams of ephedrine or
pseudoephedrine, their salts or optical isomers, or salts of
optical isomers.
 
    Section 35. Retail distributors; training requirements.
    (a) Every retail distributor of any targeted
methamphetamine precursor shall train each sales employee on
the topics listed on the certification form described in
subsection (b) of this Section. This training may be conducted
by a live trainer or by means of a computer-based training
program. This training shall be completed within 30 days of the
effective date of this Act or within 30 days of the date that
each sales employee begins working for the retail distributor,
whichever of these 2 dates comes later.
    (b) Immediately after training each sales employee as
required in subsection (a) of this Section, every retail
distributor of any targeted methamphetamine precursor shall
have each sales employee read, sign, and date a certification
containing the following language:
        (1) My name is (insert name of employee) and I am an
    employee of (insert name of business) at (insert street
    address).
        (2) I understand that in Illinois there are laws
    governing the sale of certain over-the-counter medications
    that contain a chemical called ephedrine or a second
    chemical called pseudoephedrine. Medications that are
    subject to these laws are called "targeted methamphetamine
    precursors".
        (3) I understand that "targeted methamphetamine
    precursors" can be used to manufacture the illegal and
    dangerous drug methamphetamine and that methamphetamine is
    causing great harm to individuals, families, communities,
    the economy, and the environment throughout Illinois.
        (4) I understand that under Illinois law, unless they
    are at a pharmacy counter, customers can only purchase
    small "convenience packages" of "targeted methamphetamine
    precursors".
        (5) I understand that under Illinois law, customers can
    only purchase these "convenience packages" if they are 18
    years of age or older, show identification, and sign a log
    according to procedures that have been described to me.
        (6) I understand that under Illinois law, I cannot sell
    more than one "convenience package" to a single customer in
    one 24-hour period.
        (7) I understand that under Illinois law, I cannot sell
    "targeted methamphetamine precursors" to a person if I know
    that the person is going to use them to make
    methamphetamine.
        (8) I understand that there are a number of ingredients
    that are used to make the illegal drug methamphetamine,
    including "targeted methamphetamine precursors" sold in
    "convenience packages". My employer has shown me a list of
    these various ingredients, and I have reviewed the list.
        (9) I understand that there are certain procedures that
    I should follow if I suspect that a store customer is
    purchasing "targeted methamphetamine precursors" or other
    products for the purpose of manufacturing methamphetamine.
    These procedures have been described to me, and I
    understand them.
    (c) A certification form of the type described in
subsection (b) of this Section may be signed with a handwritten
signature or an electronic signature that includes a unique
identifier for each employee. The certification shall be
retained by the retail distributor for each sales employee for
the duration of his or her employment and for at least 30 days
following the end of his or her employment. Any such form shall
be made available for inspection and copying by any law
enforcement officer upon request of that officer. These records
may be kept in electronic format if they include all the
information specified in this Section in a manner that is
readily retrievable and reproducible in hard-copy format.
    (d) The Office of the Illinois Attorney General shall make
available to retail distributors the list of methamphetamine
ingredients referred to in subsection (b) of this Section.
 
    Section 40. Penalties.
    (a) Any pharmacy or retail distributor that violates this
Act is guilty of a petty offense and subject to a fine of $500
for a first offense; and $1,000 for a second offense occurring
at the same retail location as and within 3 years of the prior
offense. A pharmacy or retail distributor that violates this
Act is guilty of a business offense and subject to a fine of
$5,000 for a third or subsequent offense occurring at the same
retail location as and within 3 years of the prior offenses.
    (b) An employee or agent of a pharmacy or retail
distributor who violates this Act is guilty of a Class A
misdemeanor for a first offense, a Class 4 felony for a second
offense, and a Class 1 felony for a third or subsequent
offense.
    (c) Any other person who violates this Act is guilty of a
Class B misdemeanor for a first offense, a Class A misdemeanor
for a second offense, and a Class 4 felony for a third or
subsequent offense.
 
    Section 45. Immunity from civil liability. In the event
that any agent or employee of a pharmacy or retail distributor
reports to any law enforcement officer or agency any suspicious
activity concerning a targeted methamphetamine precursor or
other methamphetamine ingredient or ingredients, the agent or
employee and the pharmacy or retail distributor itself are
immune from civil liability based on allegations of defamation,
libel, slander, false arrest, or malicious prosecution, or
similar allegations, except in cases of willful or wanton
misconduct.
 
    Section 50. Scope of Act.
    (a) Nothing in this Act limits the scope, terms, or effect
of the Methamphetamine Control and Community Protection Act.
    (b) Nothing in this Act limits the lawful authority granted
by the Medical Practice Act of 1987, the Nursing and Advanced
Practice Nursing Act, or the Pharmacy Practice Act of 1987.
    (c) Nothing in this Act limits the authority or activity of
any law enforcement officer acting within the scope of his or
her employment.
 
    Section 55. Preemption and home rule powers.
    (a) Except as provided in subsection (b) of this Section, a
county or municipality, including a home rule unit, may
regulate the sale of targeted methamphetamine precursor and
targeted packages in a manner that is not more or less
restrictive than the regulation by the State under this Act.
This Section is a limitation under subsection (i) of Section 6
of Article VII of the Illinois Constitution on the concurrent
exercise by home rule units of the powers and functions
exercised by the State.
    (b) Any regulation of the sale of targeted methamphetamine
precursor and targeted packages by a home rule unit that took
effect on or before May 1, 2004, is exempt from the provisions
of subsection (a) of this Section.
 
    Section 900. The Illinois Controlled Substances Act is
amended by changing Sections 211, 212, 216, 304, and 312 as
follows:
 
    (720 ILCS 570/211)  (from Ch. 56 1/2, par. 1211)
    Sec. 211. The Department shall issue a rule scheduling a
substance in Schedule V if it finds that:
    (1) the substance has low potential for abuse relative to
the controlled substances listed in Schedule IV;
    (2) the substance has currently accepted medical use in
treatment in the United States; and
    (3) abuse of the substance may lead to limited
physiological dependence or psychological dependence relative
to the substances in Schedule IV, or the substance is a
targeted methamphetamine precursor as defined in the
Methamphetamine Precursor Control Act.
(Source: P.A. 83-969.)
 
    (720 ILCS 570/212)  (from Ch. 56 1/2, par. 1212)
    Sec. 212. (a) The controlled substances listed in this
section are included in Schedule V.
    (b) Any compound, mixture, or preparation containing
limited quantities of any of the following narcotic drugs, or
their salts calculated as the free anhydrous base or alkaloid
which also contains one or more non-narcotic active medicinal
ingredients in sufficient proportion to confer upon the
compound, mixture, or preparation, valuable medicinal
qualities other than those possessed by the narcotic drug alone
as set forth below:
        (1) not more than 200 milligrams of codeine, or any of
    its salts, per 100 milliliters or per 100 grams;
        (2) not more than 100 milligrams of dihydrocodeine; or
    any of its salts, per 100 milliliters or per 100 grams;
        (3) not more than 100 milligrams of ethylmorphine, or
    any of its salts, per 100 milliliters or per 100 grams;
        (4) not more than 2.5 milligrams of diphenoxylate and
    not less than 25 micrograms of atropine sulfate per dosage
    unit;
        (5) not more than 100 milligrams of opium per 100
    milliliters or per 100 grams;
        (6) not more than 0.5 milligram of difenoxin (DEA Drug
    Code No. 9618) and not less than 25 micrograms of atropine
    sulfate per dosage unit.
    (c) Buprenorphine.
    (d) Pyrovalerone.
    (d-5) Any targeted methamphetamine precursor as defined in
the Methamphetamine Precursor Control Act.
    (e) Any compound, mixture or preparation which contains any
quantity of any controlled substance when such compound,
mixture or preparation is not otherwise controlled in Schedules
I, II, III or IV.
(Source: P.A. 89-202, eff. 10-1-95.)
 
    (720 ILCS 570/216)
    Sec. 216. Ephedrine.
    (a) The following drug products containing ephedrine, its
salts, optical isomers and salts of optical isomers shall be
exempt from the application of Sections 312 and 313 of this Act
if they: (i) may lawfully be sold over-the-counter without a
prescription under the Federal Food, Drug, and Cosmetic Act;
(ii) are labeled and marketed in a manner consistent with
Section 341.76 of Title 21 of the Code of Federal Regulations;
(iii) are manufactured and distributed for legitimate
medicinal use in a manner that reduces or eliminates the
likelihood of abuse; and (iv) are not marketed, advertised, or
labeled for the indications of stimulation, mental alertness,
weight loss, muscle enhancement, appetite control, or energy:
        (1) Solid oral dosage forms, including soft gelatin
    caplets, which are formulated pursuant to 21 CFR 341 or its
    successor, and packaged in blister packs of not more than 2
    tablets per blister.
        (2) Anorectal preparations containing not more than 5%
    ephedrine.
    (b) The marketing, advertising, or labeling of any product
containing ephedrine, a salt of ephedrine, an optical isomer of
ephedrine, or a salt of an optical isomer of ephedrine, for the
indications of stimulation, mental alertness, weight loss,
appetite control, or energy, is prohibited. In determining
compliance with this requirement the Department may consider
the following factors:
        (1) The packaging of the drug product;
        (2) The name and labeling of the product;
        (3) The manner of distribution, advertising, and
    promotion of the product;
        (4) Verbal representations made concerning the
    product;
        (5) The duration, scope, and significance of abuse or
    misuse of the particular product.
    (c) A violation of this Section is a Class A misdemeanor. A
second or subsequent violation of this Section is a Class 4
felony.
    (d) This Section does not apply to dietary supplements,
herbs, or other natural products, including concentrates or
extracts, which:
        (1) are not otherwise prohibited by law; and
        (2) may contain naturally occurring ephedrine,
    ephedrine alkaloids, or pseudoephedrine, or their salts,
    isomers, or salts of isomers, or a combination of these
    substances, that:
            (i) are contained in a matrix of organic material;
        and
            (ii) do not exceed 15% of the total weight of the
        natural product.
    (e) Nothing in this Section limits the scope or terms of
the Methamphetamine Precursor Control Act.
(Source: P.A. 90-775, eff. 1-1-99.)
 
    (720 ILCS 570/304)  (from Ch. 56 1/2, par. 1304)
    Sec. 304. (a) A registration under Section 303 to
manufacture, distribute, or dispense a controlled substance or
purchase, store, or administer euthanasia drugs may be
suspended or revoked by the Department of Professional
Regulation upon a finding that the registrant:
        (1) has furnished any false or fraudulent material
    information in any application filed under this Act; or
        (2) has been convicted of a felony under any law of the
    United States or any State relating to any controlled
    substance; or
        (3) has had suspended or revoked his Federal
    registration to manufacture, distribute, or dispense
    controlled substances or purchase, store, or administer
    euthanasia drugs; or
        (4) has been convicted of bribery, perjury, or other
    infamous crime under the laws of the United States or of
    any State; or
        (5) has violated any provision of this Act or any rules
    promulgated hereunder, or any provision of the
    Methamphetamine Precursor Control Act or rules promulgated
    thereunder, whether or not he has been convicted of such
    violation; or
        (6) has failed to provide effective controls against
    the diversion of controlled substances in other than
    legitimate medical, scientific or industrial channels.
    (b) The Department of Professional Regulation may limit
revocation or suspension of a registration to the particular
controlled substance with respect to which grounds for
revocation or suspension exist.
    (c) The Department of Professional Regulation shall
promptly notify the Administration, the Department and the
Department of State Police or their successor agencies, of all
orders denying, suspending or revoking registration, all
forfeitures of controlled substances, and all final court
dispositions, if any, of such denials, suspensions,
revocations or forfeitures.
    (d) If Federal registration of any registrant is suspended,
revoked, refused renewal or refused issuance, then the
Department of Professional Regulation shall issue a notice and
conduct a hearing in accordance with Section 305 of this Act.
(Source: P.A. 93-626, eff. 12-23-03.)
 
    (720 ILCS 570/312)  (from Ch. 56 1/2, par. 1312)
    Sec. 312. Requirements for dispensing controlled
substances.
    (a) A practitioner, in good faith, may dispense a Schedule
II controlled substance, which is a narcotic drug listed in
Section 206 of this Act; or which contains any quantity of
amphetamine or methamphetamine, their salts, optical isomers
or salts of optical isomers; phenmetrazine and its salts; or
pentazocine; and Schedule III, IV, or V controlled substances
to any person upon a written prescription of any prescriber,
dated and signed by the person prescribing on the day when
issued and bearing the name and address of the patient for
whom, or the owner of the animal for which the controlled
substance is dispensed, and the full name, address and registry
number under the laws of the United States relating to
controlled substances of the prescriber, if he is required by
those laws to be registered. If the prescription is for an
animal it shall state the species of animal for which it is
ordered. The practitioner filling the prescription shall write
the date of filling and his own signature on the face of the
written prescription. The written prescription shall be
retained on file by the practitioner who filled it or pharmacy
in which the prescription was filled for a period of 2 years,
so as to be readily accessible for inspection or removal by any
officer or employee engaged in the enforcement of this Act.
Whenever the practitioner's or pharmacy's copy of any
prescription is removed by an officer or employee engaged in
the enforcement of this Act, for the purpose of investigation
or as evidence, such officer or employee shall give to the
practitioner or pharmacy a receipt in lieu thereof. A
prescription for a Schedule II controlled substance shall not
be filled more than 7 days after the date of issuance. A
written prescription for Schedule III, IV or V controlled
substances shall not be filled or refilled more than 6 months
after the date thereof or refilled more than 5 times unless
renewed, in writing, by the prescriber.
    (b) In lieu of a written prescription required by this
Section, a pharmacist, in good faith, may dispense Schedule
III, IV, or V substances to any person either upon receiving a
facsimile of a written, signed prescription transmitted by the
prescriber or the prescriber's agent or upon a lawful oral
prescription of a prescriber which oral prescription shall be
reduced promptly to writing by the pharmacist and such written
memorandum thereof shall be dated on the day when such oral
prescription is received by the pharmacist and shall bear the
full name and address of the ultimate user for whom, or of the
owner of the animal for which the controlled substance is
dispensed, and the full name, address, and registry number
under the law of the United States relating to controlled
substances of the prescriber prescribing if he is required by
those laws to be so registered, and the pharmacist filling such
oral prescription shall write the date of filling and his own
signature on the face of such written memorandum thereof. The
facsimile copy of the prescription or written memorandum of the
oral prescription shall be retained on file by the proprietor
of the pharmacy in which it is filled for a period of not less
than two years, so as to be readily accessible for inspection
by any officer or employee engaged in the enforcement of this
Act in the same manner as a written prescription. The facsimile
copy of the prescription or oral prescription and the written
memorandum thereof shall not be filled or refilled more than 6
months after the date thereof or be refilled more than 5 times,
unless renewed, in writing, by the prescriber.
    (c) Except for any targeted methamphetamine precursor as
defined in the Methamphetamine Precursor Control Act, a A
controlled substance included in Schedule V shall not be
distributed or dispensed other than for a medical purpose and
not for the purpose of evading this Act, and then:
        (1) only personally by a person registered to dispense
    a Schedule V controlled substance and then only to his
    patients, or
        (2) only personally by a pharmacist, and then only to a
    person over 21 years of age who has identified himself to
    the pharmacist by means of 2 positive documents of
    identification.
        (3) the dispenser shall record the name and address of
    the purchaser, the name and quantity of the product, the
    date and time of the sale, and the dispenser's signature.
        (4) no person shall purchase or be dispensed more than
    120 milliliters or more than 120 grams of any Schedule V
    substance which contains codeine, dihydrocodeine, or any
    salts thereof, or ethylmorphine, or any salts thereof, in
    any 96 hour period. The purchaser shall sign a form,
    approved by the Department of Professional Regulation,
    attesting that he has not purchased any Schedule V
    controlled substances within the immediately preceding 96
    hours.
        (5) a copy of the records of sale, including all
    information required by paragraph (3), shall be forwarded
    to the Department of Professional Regulation at its
    principal office by the 15th day of the following month.
        (6) all records of purchases and sales shall be
    maintained for not less than 2 years.
        (7) no person shall obtain or attempt to obtain within
    any consecutive 96 hour period any Schedule V substances of
    more than 120 milliliters or more than 120 grams containing
    codeine, dihydrocodeine or any of its salts, or
    ethylmorphine or any of its salts. Any person obtaining any
    such preparations or combination of preparations in excess
    of this limitation shall be in unlawful possession of such
    controlled substance.
        (8) a person qualified to dispense controlled
    substances under this Act and registered thereunder shall
    at no time maintain or keep in stock a quantity of Schedule
    V controlled substances defined and listed in Section 212
    (b) (1), (2) or (3) in excess of 4.5 liters for each
    substance; a pharmacy shall at no time maintain or keep in
    stock a quantity of Schedule V controlled substances as
    defined in excess of 4.5 liters for each substance, plus
    the additional quantity of controlled substances necessary
    to fill the largest number of prescription orders filled by
    that pharmacy for such controlled substances in any one
    week in the previous year. These limitations shall not
    apply to Schedule V controlled substances which Federal law
    prohibits from being dispensed without a prescription.
        (9) no person shall distribute or dispense butyl
    nitrite for inhalation or other introduction into the human
    body for euphoric or physical effect.
    (d) Every practitioner shall keep a record of controlled
substances received by him and a record of all such controlled
substances administered, dispensed or professionally used by
him otherwise than by prescription. It shall, however, be
sufficient compliance with this paragraph if any practitioner
utilizing controlled substances listed in Schedules III, IV and
V shall keep a record of all those substances dispensed and
distributed by him other than those controlled substances which
are administered by the direct application of a controlled
substance, whether by injection, inhalation, ingestion, or any
other means to the body of a patient or research subject. A
practitioner who dispenses, other than by administering, a
controlled substance in Schedule II, which is a narcotic drug
listed in Section 206 of this Act, or which contains any
quantity of amphetamine or methamphetamine, their salts,
optical isomers or salts of optical isomers, pentazocine, or
methaqualone shall do so only upon the issuance of a written
prescription blank by a prescriber.
    (e) Whenever a manufacturer distributes a controlled
substance in a package prepared by him, and whenever a
wholesale distributor distributes a controlled substance in a
package prepared by him or the manufacturer, he shall securely
affix to each package in which that substance is contained a
label showing in legible English the name and address of the
manufacturer, the distributor and the quantity, kind and form
of controlled substance contained therein. No person except a
pharmacist and only for the purposes of filling a prescription
under this Act, shall alter, deface or remove any label so
affixed.
    (f) Whenever a practitioner dispenses any controlled
substance except a non-prescription targeted methamphetamine
precursor as defined in the Methamphetamine Precursor Control
Act, he shall affix to the container in which such substance is
sold or dispensed, a label indicating the date of initial
filling, the practitioner's name and address, the name of the
patient, the name of the prescriber, the directions for use and
cautionary statements, if any, contained in any prescription or
required by law, the proprietary name or names or the
established name of the controlled substance, and the dosage
and quantity, except as otherwise authorized by regulation by
the Department of Professional Regulation. No person shall
alter, deface or remove any label so affixed.
    (g) A person to whom or for whose use any controlled
substance has been prescribed or dispensed by a practitioner,
or other persons authorized under this Act, and the owner of
any animal for which such substance has been prescribed or
dispensed by a veterinarian, may lawfully possess such
substance only in the container in which it was delivered to
him by the person dispensing such substance.
    (h) The responsibility for the proper prescribing or
dispensing of controlled substances is upon the prescriber and
the responsibility for the proper filling of a prescription for
controlled substance drugs rests with the pharmacist. An order
purporting to be a prescription issued to any individual, which
is not in the regular course of professional treatment nor part
of an authorized methadone maintenance program, nor in
legitimate and authorized research instituted by any
accredited hospital, educational institution, charitable
foundation, or federal, state or local governmental agency, and
which is intended to provide that individual with controlled
substances sufficient to maintain that individual's or any
other individual's physical or psychological addiction,
habitual or customary use, dependence, or diversion of that
controlled substance is not a prescription within the meaning
and intent of this Act; and the person issuing it, shall be
subject to the penalties provided for violations of the law
relating to controlled substances.
    (i) A prescriber shall not preprint or cause to be
preprinted a prescription for any controlled substance; nor
shall any practitioner issue, fill or cause to be issued or
filled, a preprinted prescription for any controlled
substance.
    (j) No person shall manufacture, dispense, deliver,
possess with intent to deliver, prescribe, or administer or
cause to be administered under his direction any anabolic
steroid, for any use in humans other than the treatment of
disease in accordance with the order of a physician licensed to
practice medicine in all its branches for a valid medical
purpose in the course of professional practice. The use of
anabolic steroids for the purpose of hormonal manipulation that
is intended to increase muscle mass, strength or weight without
a medical necessity to do so, or for the intended purpose of
improving physical appearance or performance in any form of
exercise, sport, or game, is not a valid medical purpose or in
the course of professional practice.
(Source: P.A. 90-253, eff. 7-29-97; 91-576, eff. 4-1-00;
91-714, eff. 6-2-00.)
 
    (720 ILCS 647/Act rep.)
    Section 905. The Methamphetamine Precursor Retail Sale
Control Act is repealed.
 
    Section 999. Effective date. This Act takes effect January
15, 2006.

Effective Date: 1/15/2006